Announcement: New Journal Title

Dear Readers,

Through this official announcement, we are excited to announce that based on the decision made by the journal editorial board, the title will be altered on Nov 2023. It means that from 3 (4), all articles will be published under the new title.

We hope that by changing the title, its international representation will be increased and improved. The process to change the title and scope was led by Dr. Abdolkarim Sheikhi (EIC) and some of our distinguished editors spent considerable time evaluating the name and scope change and how it would impact the journal and readership.

Finally, the changes were approved by the Editorial Board and the Publisher. The old title of this journal was a well-known journal among all researchers in the field of all areas of Medical and Biomedical Sciences since 2021. We continue our commitment to a double-blind peer-reviewed journal for original research articles and review articles in all areas of Immunopharmacology. Therefore, nothing in the Journal of Advanced Immunopharmacology will be changed and shall remain as before. However, by this critical change, we could publish more high-quality and focused articles in the field of immunopharmacology.

The Journal of Advanced Immunopharmacology will continue to publish original research and review articles in all areas of Immunopharmacology, following a double-blind peer-review process. The changes will not affect the journal's content but will allow us to publish more high-quality and focused articles in this field.

Kind Regards,        
Dr. Abdolkarim Sheikhi Editor in Chief